Biolife Sciences Stock Market Value
BLFE Stock | USD 0.0001 0.00 0.00% |
Symbol | BioLife |
BioLife Sciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioLife Sciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioLife Sciences.
10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in BioLife Sciences on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding BioLife Sciences or generate 0.0% return on investment in BioLife Sciences over 30 days. BioLife Sciences is related to or competes with GlucoTrack, Sharps Technology, Predictive Oncology, Bionano Genomics, Meihua International, Nexgel, and Pro Dex. Bio Life Sciences Corp. develops, licenses, and distributes antibacterial products and non-contact human temperature scr... More
BioLife Sciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioLife Sciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioLife Sciences upside and downside potential and time the market with a certain degree of confidence.
BioLife Sciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioLife Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioLife Sciences' standard deviation. In reality, there are many statistical measures that can use BioLife Sciences historical prices to predict the future BioLife Sciences' volatility.BioLife Sciences Backtested Returns
We have found three technical indicators for BioLife Sciences, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and BioLife Sciences are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
BioLife Sciences has no correlation between past and present. Overlapping area represents the amount of predictability between BioLife Sciences time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioLife Sciences price movement. The serial correlation of 0.0 indicates that just 0.0% of current BioLife Sciences price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.0 | |
Spearman Rank Test | 1.0 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
BioLife Sciences lagged returns against current returns
Autocorrelation, which is BioLife Sciences pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioLife Sciences' pink sheet expected returns. We can calculate the autocorrelation of BioLife Sciences returns to help us make a trade decision. For example, suppose you find that BioLife Sciences has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
BioLife Sciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioLife Sciences pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioLife Sciences pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioLife Sciences pink sheet over time.
Current vs Lagged Prices |
Timeline |
BioLife Sciences Lagged Returns
When evaluating BioLife Sciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioLife Sciences pink sheet have on its future price. BioLife Sciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioLife Sciences autocorrelation shows the relationship between BioLife Sciences pink sheet current value and its past values and can show if there is a momentum factor associated with investing in BioLife Sciences.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BioLife Pink Sheet
BioLife Sciences financial ratios help investors to determine whether BioLife Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLife with respect to the benefits of owning BioLife Sciences security.